Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissues, announced this week it has raised $32 million in additional funding. The round included The 4100 Group, East Post Road Ventures (Investment Arm of White Plains Hospital), Epiphron Capital, Northwell Ventures, P5 Health Ventures, and participation from other strategic organizations. This brings the total raised by Clarapath to more than $39 million. Clarapath is automating processes around the way tissue is processed onto glass slides via “sectioning,” or cutting a cross-section of the tissue specimen. The company’s first robotic instrument, called SectionStar, […]